EDMONTON, Alberta--BioTools announced that it secured a round of financing from private investment group Western New Ventures Capital. The University of Alberta spinoff, which was incorporated in 1996, said the funding would allow it to accelerate development and market entry of PepTool and GeneTool, its protein and DNA sequence analysis software products. BioTools said it would also be expanding its laboratory division.
BioTools Gets Financing
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.